Identifying early signs of Alzheimer's disease through sensory measures
Multi-Domain Sensory Measures as Biomarkers of Alzheimer's Disease in Preclinical and Prodromal Stages
This study is looking for new, easy ways to spot Alzheimer's disease early by checking how well people can see, smell, and hear, which could help doctors start treatment sooner and improve outcomes for those at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10614919 on NIH RePORTER |
What this research studies
This research focuses on developing sensitive and non-invasive methods to detect Alzheimer's disease (AD) in its early stages. By examining sensory functions such as vision, smell, and hearing, the study aims to identify biomarkers that can indicate the presence of AD before significant cognitive decline occurs. The approach involves using advanced neuroimaging tools and combining sensory measures from multiple domains to improve early detection. This could help target individuals for therapeutic interventions sooner, potentially improving patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include older adults who may be experiencing subtle sensory impairments or are at risk for developing Alzheimer's disease.
Not a fit: Patients with advanced Alzheimer's disease or those who do not exhibit any sensory impairments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier identification of Alzheimer's disease, allowing for timely therapeutic and lifestyle interventions.
How similar studies have performed: Previous research has shown promise in using sensory measures as early indicators of cognitive decline, suggesting that this approach could be effective.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Risacher, Shannon L — Indiana University Indianapolis
- Study coordinator: Risacher, Shannon L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.